INTRODUCTION
Osteoarthritis (OA) is a group of chronic painful, disabling conditions affecting the synovial joints. It results from articular cartilage failure induced by a complex interplay of genetic, metabolic, biochemical, and biomedical factors with secondary components of inflammation. The process involves interactive degradation and repair processes of cartilage, bone and synovium. Osteoarthritis is the most common form of arthritis (1) .
Among US adults 30 years of age and older, symptomatic disease in the knee occurs in approximately 6% and symptomatic hip osteoarthritis in roughly 3%. Unfortunately we do not have figures to quote here in Kenya. Osteoarthritis is commonly described as a non inflammatory disease which distinguishes from inflammatory arthritis, such as rheumatoid arthritis (RA) or seronegative spondyloarthropathies. Despite this, inflammation is increasingly recognized as contributing to the symptoms and progression of OA. Chondrocytes are probably the most important cells responsible for the development of the osteoarthritic process. Human and animal studies indicate that chondrocytes exhibit numerous abnormal metabolic features as part of the osteoarthritic process. These include increased levels of proliferative (2, 3) , synthetic (4, 5) The initiation of the osteoarthritic process therefore appears to involve abnormalities in biomechanical forces and/or cartilage. Once begun, the pathway leading to osteoarthritis involves numerous other factors. These include mechanotransduction, the interplay between proteases, protease inhibitors and cytokines on cartilage degradation and mechanisms of cartilage repair and the contributions from multiple risk factors (such as obesity, aging, mineral deposition, systemic hormones, and abnormalities in neurogenic control). An abnormality associated with osteoarthritis extends beyond the cartilage often involving the subchondral bone, juxtaarticular bone marrow and the synovial membrane.
PATHOPHYSIOLOGY OF OSTEOARTHRITIS
A normal cartilage is avascular, alymphatic and aneural and is smooth and resilient in turn allowing shearing and compressive forces to be dissipated uniformly along a joint. The cartilage matrix is made up of water and gel (ground substance), which 
Degradation Regeneration
Cartilage metabolism in OA normally provides a "give", proteoglycans, and collagen.
Metallo proteases: A great deal of attention has been focused on identifying the protease responsible for the initial occurrence of matrix digestion. Current knowledge indicates an involvement of matrix metalloproteases (MMP). Of this family, members from three groups in human articular tissues have been identified as being elevated in OA that is the collagenases, the stromelysins and the gelatinases. Another group of MMP, localized at the cell membrane surface, has recently been discovered, and named membrane type MMP (MT-MMP), however the relevance of these enzymes to OA has yet to be determined. MMP biologic activity is controlled physiologically by specific tissue inhibitors of metallo-proteases (TIMP) or by their activation. Enzymes from the serine-and cysteine-dependent protease families, such as the plasminogen activation/plasmin system and cathepsin B respectively, has been proposed as activators, and enhanced levels of urokinase (uPA) and plasmin have been identified in human OA cartilage. Other enzymes that have been found to act as MMP activators, for example stromelysin-1, activates collagenase-1, collagenase-3, and gelatinase 92kD;collagenase-3 activates gelatinase92kD,MT-MMP activates collagenase-3 and gelatinase-72kD potentiates the later activation; MT-MMP also activates gelatinase 72kd (7) .
Inflammatory cytokines: Current evidence suggests that proinflammatory cytokines are responsible for the catabolic process occurring in the pathological tissues. They appear to be first produced by the synovial membrane, and diffused into the cartilage through the synovial fluid, where Cascade of Pathology they activate the chondrocytes to produce proinflammatory cytokines. In OA synovial membrane, it is the synovial lining cells that play a major role as inflammatory effectors of which interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6, leukemic inhibitor factor (LIF) and IL-17 appear most relevant to the disease. Data strongly suggests the concept that IL-1β and perhaps TNF-α are the major catabolic systems involved in the destruction of joint tissues, and may constitute the in situ source of articular tissue damage and degradation. However it is not clear whether IL-1β and TNF-α act independently or in concert to induce the pathogenesis of OA, or if a functional hierarchy exists between these proinflammatory cytokines. In animal models, it has been shown that blocking IL-1 or its activity is very effective in preventing cartilage destruction(8), whereas blocking TNF-α results in decreased inflammation(9), however both cytokines have been found in enhanced amounts in OA synovial membrane, synovial fluid and cartilage. IL-6 has been shown to be the contributor to OA pathological process by :
Figure 3
The involvement of the various cytokines in the process of osteoarthritis in turn affecting the quality of the cartilage matrix the increased MMP synthesis and inhibition of proteoglycan production. However IL-6 is involved in the feedback mechanism that limits enzyme production by also inducing the production of tissue inhibitor of matrix metalloproteinase's. LIF a cytokine of IL-6 family is also up regulated in OA synovial membrane and fluid and is produced by chondrocytes in response to proinflammatory cytokines which stimulates cartilage proteoglycan resorption, as well as MMP synthesis and NO cellular production; however its role in OA has not yet been clearly defined. IL-17 is a new cytokine that has been shown to up regulate a number of gene products involved in cell activation.
Nitrous Oxide: Inorganic free radical NO has also been suggested a factor that promotes cartilage catabolism in OA (10) . A number of studies are on going to understand the molecular mechanisms underlying NO signaling and their effects on the cartilage.
•CytokinesIl1,TNF-Alpha Pathogenesis of osteoarthritis….
•Growth Factors
Calcium Crystals: Calcium pyrophosphate has been shown to coexist with cartilage damage in some patients with OA, however what is not known as whether the crystals cause the cartilage damage or whether cartilage damage results in the formation of crystals. Calcium pyrophosphate has shown to be mitogenic; up regulate MMP's; stimulate the production of COX-1 and -2 and PGE2 production; stimulate cytokine production (IL) 10; and induce the production of NO production (11) .
Leptins: Leptins have also been shown to play an important role in OA. There has been up regulation of leptin levels in synovial fluid, cartilage and osteophytes and its levels have been shown to correlate with the BMI; thus it is a key regulator of chondrocyte metabolism (12) .
Angiogenesis: Recently angiogenesis and inflammation have been shown to play an important role in OA and may affect disease progression and pain. Angiogenesis and chronic inflammation are closely integrated processes. Inflammation can stimulate angiogenesis, and angiogenesis can in turn facilitate inflammation, including chondrocyte hypertrophy and endochondral ossification. Inflammation may facilitate angiogenesis directly through the release of growth factors from cells such as macrophages, and also by stimulation or sensitization of other cells, such chondrocytes, nerves and osteoblasts, which in turn release additional angiogenic factors. Angiogenesis at the osteochondral junction leads to endochondral ossification and the formation of osteophytes. Angiogenesis and joint damage further exacerbate inflammation. New vessels, which breach the tidemark may later become innervated and could be a source of pain. Through these mechanisms, angiogenesis and inflammation can contribute pain and joint damage. Recent studies have implicated nitric oxide (NO) as a potential mediator of cartilage pathophysiology in osteoarthritis. NO exerts a major role in cartilage destruction and caused a pronounced suppression of proteogycan synthesis and IGF-1 unresponsiveness of the chondrocytes and also disrupts the cytoskeletal signaling complex associated wih integrin signaling. Unidentified genetic factors have also been implicated in the development of OA and a genetic component is supported by studies of families and twins. Clonal chromosomal aberrations, such as the gain of chromosomes 5 and 7, were observed in the synovial membrane of certain patients with OA. Alpha1-antitrypsin, α1-antichymotrypsin, gene polymorphisms and HLA alleles have been associated with generalized OA (13).
T Cells: As noted earlier that inflammation in the synovial membrane of at least 50% of patients with OA is well documented. This inflammatory response exhibits features of a T cell immune response (14) . 
